Intravenous ibandronate (Boniva) is offered as an alternative to oral agents for patients with osteoporosis. Treatments are given every three months and take less than five minutes. Please note that there may be manufacturer’s backlog affecting the availability of this drug and it is FDA-approved for use in women only.
Reclast (zoledronic acid) recently became the second IV bisphosphonate FDA approved for the treatment of osteoporosis. Treatments are given annually. Treatments are given annually and it is approved for use in men and women.
Prolia (denosumab) is a prescription medicine used to treat osteoporosis in postmenopausal women and men who:
– are at high risk for fracture, meaning women who have had a fracture related to osteoporosis, or who have multiple risk factors for fracture
– cannot use another osteoporosis medicine or other osteoporosis medicines did not work well
For patients undergoing dental work or for more information concerning osteonecrosis of the jaw, a rare complication of IV bisphoshphonate treatment please go to:http://www.medicalnewstoday.com/articles/40774.php
For more information concerning a particular drug go to medications.